Subscribe: Brightsurf Science News :: Endometrial Cancer News
Added By: Feedage Forager Feedage Grade A rated
Language: English
breast cancer  breast  cancer cells  cancer  cell  cells  new study  new  research  researchers  risk  study  university 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Brightsurf Science News :: Endometrial Cancer News

Endometrial Cancer Current Events and Endometrial Cancer News from Brightsurf

Endometrial Cancer Current Events and Endometrial Cancer News Events, Discoveries and Articles from Brightsurf

Copyright: Copyright 2017,

Many cancer survivors are living with PTSD

Mon, 20 Nov 17 00:16:10 -0800

A recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later.

Special Focus Issue of Future Oncology highlights advances in image guided therapy

Mon, 20 Nov 17 00:05:10 -0800

The Future Science Group (FSG) published journal, Future Oncology, has released a special focus issue that examines the field of image guided therapy in oncology, highlighting the latest advancements in image guided therapy and the application of several techniques in a number of cancer types.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

Mon, 20 Nov 17 00:01:10 -0800

A new study by researchers at The Ohio State University Comprehensive Cancer Center -- James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages.

UVA researchers discover a new target for 'triple-negative' breast cancer

Mon, 20 Nov 17 00:02:50 -0800

One of the most difficult to treat cancers - triple-negative breast cancer - may be vulnerable to a new approach, an early study indicates.

University of Guelph professor identifies protein key to cancer cells ability to spread

Fri, 17 Nov 17 00:08:50 -0800

U of G scientists have made a discovery that could reduce the spread of cancer by hindering a protein that binds cancer cells together and allows them to invade tissues. The groundbreaking study identified a protein, known as cadherin-22, as a potential factor in cancer metastasis, or spread, and showed that hindering it decreased the adhesion and invasion rate of breast and brain cancer cells by up to 90 percent.

Link between obesity and cancer is not widely recognized

Fri, 17 Nov 17 00:07:40 -0800

A new study published in the Journal of Public Health has shown that the majority of people in the United Kingdom do not understand the connection between weight issues and cancer. Obesity is associated with thirteen types of cancer, including those of the breast, kidney, bowel, and womb. However, after surveying 3293 adults, taken as representative of the UK population, researchers found that only a quarter of respondents were aware of the link between obesity and cancer.

How a poorly explored immune cell may impact cancer immunity and immunotherapy

Fri, 17 Nov 17 00:13:20 -0800

The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells. But a new study takes a step back and considers: What if the problem isn't with the effector T-cells but starts higher up the cellular chain?

Why are minorities underrepresented in genetic cancer studies?

Thu, 16 Nov 17 00:02:50 -0800

Socio-cultural and clinical factors as well as healthcare processes were important drivers of a woman's willingness to provide saliva specimens for future cancer research. This is according to Vanessa B. Sheppard of Virginia Commonwealth University's School of Medicine, lead author of a study in Springer's Journal of Cancer Survivorship.

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

Thu, 16 Nov 17 00:10:10 -0800

A discovery might help designers of miniature 'lab-on-a-chip' technologies to grow three-dimensional colonies of cancer cells inside a chip's tiny chambers, rather than the merely two-dimensional colonies that they generally can culture now. Chips with 3-D cell arrays could furnish more realistic biological environments for drug testing.

Type 2 diabetes associated with risk of aggressive breast cancer in black women

Wed, 15 Nov 17 00:13:50 -0800

African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.

African-American women with type 2 diabetes may have higher risk for ER-neg breast cancer

Wed, 15 Nov 17 00:13:40 -0800

Among African-American women, those with type 2 diabetes may have a higher risk of developing estrogen receptor (ER)-negative breast cancer.

Tapeworm drug fights prostate cancer

Wed, 15 Nov 17 00:00:30 -0800

A medicine against parasites contains a substance that kills prostate and colon cancer.

Insurance linked to black-white survival disparities in colorectal cancer

Tue, 14 Nov 17 00:11:50 -0800

Health insurance coverage differences account for nearly one-half of the black-white survival disparity in colorectal cancer patients, according to a new study.

Dresden scientists develop a sensor for the most important human cancer gene

Tue, 14 Nov 17 00:12:50 -0800

The molecular smoke detector works like a TP53 sensor, which monitors the correct function of the gene. A non-functional TP53 gene is going to activate the sensor, which initiates cell death. Results from this study from the research team of Prof. Frank Buchholz are now published in the journal Nature Communications.

Development of new protein may lead to novel treatment options for cancer, birth defects

Tue, 14 Nov 17 00:04:20 -0800

Researchers have engineered an artificial protein that may block malignant properties of cancer cells as well as correct certain birth defects. The findings, which appear in the journal Proceedings of the National Academy of Sciences, may lead to identifying new molecular targets suitable for therapeutic intervention.

A new strategy for prevention of liver cancer development

Tue, 14 Nov 17 00:06:00 -0800

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs. However, an unexpected finding made by a team of University of California San Diego School of Medicine researchers sheds light on the development of a new strategy for prevention of liver cancer.

Cornell study reveals why testicular cancer is so responsive to chemo

Tue, 14 Nov 17 00:05:40 -0800

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?

Epigenetic editing reveals surprising insights into early breast cancer development

Mon, 13 Nov 17 00:04:00 -0800

Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London (QMUL).

Ludwig scientists share findings at 2017 Society for Neuro-oncology Annual Meeting

Mon, 13 Nov 17 00:07:10 -0800

Ludwig Cancer Research has released the scope of its participation at this year's Annual Meeting and Education Day of the Society for Neuro-Oncology in San Francisco, California, Nov. 16-19.

Engineering non-immune cells to kill cancer cells

Mon, 13 Nov 17 00:14:20 -0800

ETH researchers have reprogrammed normal human cells to create designer immune cells capable of detecting and destroying cancer cells.

Harder for T cells to fight cancer in absence of VEGF-A

Mon, 13 Nov 17 00:02:00 -0800

Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment when they have access to growth factor VEGF-A. In a study from Karolinska Institutet published in Cancer Cell, the researchers show how the T cells not only survive in this oxygen-depleted micro-environment with the help of transcription factor HIF-1a but also become more effective at killing cancer cells inside it.

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers

Mon, 13 Nov 17 00:08:40 -0800

Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer.

UK study shows cell signaling interaction may prevent key step in lung cancer progression

Thu, 09 Nov 17 00:13:50 -0800

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.

Scientists figure out how cell division timer works

Thu, 09 Nov 17 00:00:20 -0800

Human cells use a timer to divide: each cell gets at least 30 minutes to divide its genetic material between the nuclei of two daughter cells. Researchers at KU Leuven, Belgium, have unravelled how this timer is switched on and off. Their findings open up perspectives for the treatment of cancer, as keeping the timer going would stop cancer cells from dividing.

HPV jab means women only need 3 cervical screens in a lifetime

Thu, 09 Nov 17 00:06:50 -0800

Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to a new study published in the International Journal of Cancer today.

Mutant gene network in colon cancer identified

Thu, 09 Nov 17 00:09:00 -0800

The principles of the gene network for colon tumorigenesis have been identified by a KAIST research team. The principles will be used to find the molecular target for effective anti-cancer drugs in the future. Further, this research gained attention for using a systems biology approach, which is an integrated research area of IT and BT.

Dietary isoflavones linked to increased risk of advanced prostate cancer

Wed, 08 Nov 17 00:05:10 -0800

Dietary intake of isoflavones was linked with an elevated risk of advanced prostate cancer in a recent International Journal of Cancer study.

Study finds a new way to shut down cancer cells' ability to consume glucose

Tue, 07 Nov 17 00:12:50 -0800

Many cancers depend on glucose consumption for energy, but good pharmacological targets to stop cancers' ability to uptake and metabolize glucose are missing. A University of Colorado Cancer Cancer Center study published today finally identifies a way to restrict the ability of cancer to use glucose for energy.

Is anticoagulant warfarin associated with lower risk of cancer incidence?

Mon, 06 Nov 17 00:08:30 -0800

Bottom Line: Use of the blood thinner warfarin was associated with a lower risk of new cancers in people over 50.

Flavonoid derivatives targeting NF-kappaB

Mon, 06 Nov 17 00:13:30 -0800

The aim of the study was to develop new synthetic anti-inflammatory and cytotoxic agents targeting NF-kappaB.

Ludwig scientists share research at The Society for Immunotherapy of Cancer annual meeting

Mon, 06 Nov 17 00:00:00 -0800

Ludwig Cancer Research has released the scope of its participation at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, Maryland, Nov. 8-12.

Important new insights into RECIST criteria measuring cancer's response to treatment

Mon, 06 Nov 17 00:01:00 -0800

University of Colorado Cancer Center study examines current RECIST guidelines in an effort to bring them up to speed with new complexities presented by the latest targeted therapies.

Biologics do not increase the risk of second malignancy in rheumatoid arthritis patients

Sat, 04 Nov 17 00:09:50 -0700

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

Younger women with advanced breast cancer needlessly excluded from treatment trials

Sat, 04 Nov 17 00:01:20 -0700

Pre-menopausal women with the most common type of advanced breast cancer are usually excluded from medical research unnecessarily, according to an expert panel at the Advanced Breast Cancer Fourth International Consensus Conference.

Two important signalling pathways in cancer and ageing are connected for the first time

Thu, 02 Nov 17 00:00:30 -0700

Two years ago, a group led by Maria A. Blasco at the Spanish National Cancer Research Centre (CNIO) hit upon several compounds that caused injury to the telomeres and now, in a study published in Nature Communications, they show that these drugs achieve this effect by acting on PI3K, a key protein in cancer and ageing. This is the first time that a functional link has been described between this pathway and the telomeres.

Exercise can counteract side-effects and improve fitness in advanced breast cancer patients

Thu, 02 Nov 17 00:08:10 -0700

Taking part in regular exercise can reduce fatigue and pain, and improve cardiovascular health and quality of life in women being treated for advanced breast cancer, according to new research presented at the Advanced Breast Cancer Fourth International Consensus Conference.

Unveiling gut microbes' influence on cancer patient response to immunotherapy

Thu, 02 Nov 17 00:11:40 -0700

Two new studies in cancer patients demonstrate how the composition of gut bacteria can influence response to immunotherapy. Antibiotics, one study showed, render such treatments less effective.

Scientists link pancreatic cancer survival to four genes

Thu, 02 Nov 17 00:13:30 -0700

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in Jama Oncology.

Breast cancer researchers track changes in normal mammary duct cells leading to disease

Wed, 01 Nov 17 00:12:40 -0700

Breast cancer researchers have mapped early genetic alterations in normal-looking cells at various distances from primary tumors to show how changes along the lining of mammary ducts can lead to disease.

It is time for a concerted European approach to defeat cancer

Wed, 01 Nov 17 00:16:00 -0700

ESMO President, Fortunato Ciardiello, has contributed an editorial on the priorities for future cancer research, to The Lancet Oncology with Josep Tabernero, ESMO President-Elect as co-author. The review refers to the publication on Future Cancer Research Priorities in the USA and to the American Cancer Moonshot Task Force, and highlights the urgent need for a similar integrated approach within the EU.

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors

Wed, 01 Nov 17 00:02:50 -0700

University of Colorado Cancer Center studies presented this weekend at AACR Molecular Targets and Cancer Therapeutics Meeting show that using the drug alisertib along with the drug TAK-228 is more effective against triple-negative breast cancer and solid tumors than either drug alone.

Infertility linked to higher risk of death among women

Wed, 01 Nov 17 00:03:40 -0700

Women with a history of infertility have a 10 percent increased risk of death compared to those without reported infertility struggles, according to results of a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. The study, which examined the association between infertility and mortality as well as specific causes of death, also showed that women with a history of infertility have a 20 percent increased risk of cancer-related mortality.

New toolkit reveals novel cancer genes

Tue, 31 Oct 17 00:11:20 -0700

A new statistical model has enabled researchers to pinpoint 27 novel genes thought to prevent cancer from forming, in an analysis of over 2,000 tumors across 12 human cancer types. The findings could help create new cancer treatments that target these genes, and open up other avenues of cancer research.

Experts call for virtual European cancer institute/infrastructure

Tue, 31 Oct 17 00:15:10 -0700

A new article that addresses the challenges of cancer proposes combining innovative prevention and treatment strategies in a state-of-the-art virtual European Cancer Institute/Infrastructure that promotes sharing of the highest standards of practices and big data among countries and centers across Europe and beyond.

Air pollution is associated with cancer mortality beyond lung cancer

Tue, 31 Oct 17 00:02:50 -0700

A large scale epidemiological study associates some air pollutants with kidney, bladder and colorectal cancer death.

Long-term use of drugs to curb acid reflux linked to doubling in stomach cancer risk

Tue, 31 Oct 17 00:07:30 -0700

The long-term use of proton pump inhibitors (PPIs), a class of drugs commonly used to treat acid reflux, is linked to a more than doubling in the risk of developing stomach cancer, finds research published online in the journal Gut.

Rousing masses to fight cancer with open source machine learning

Mon, 30 Oct 17 00:03:10 -0700

Sharing is caring in the fight against cancer with this new open source software project to predict cancer drug effectiveness. Georgia Tech researchers have kicked off the project with a program they tested to be about 85% effective in making predictions in individual patient treatments in their new study. It's free for the downloading, and the study details the research behind it.

Scientists discover surprising immune cell activity that may be limiting immunotherapy

Mon, 30 Oct 17 00:08:20 -0700

Researchers have uncovered a surprising process within a key immune cell that may help explain the limitations of immunotherapy as a cancer treatment.

An experimental model might shed new light on the development of brain cancer in children

Fri, 27 Oct 17 00:01:40 -0700

Researchers of the German Center for Neurodegenerative Diseases (DZNE) present in the journal Cancer Cell a novel laboratory model that replicates key hallmarks of pediatric high-grade glioma. Results might pave the way for a better understanding of processes, relevant for both cancer and neurodegeneration.

Cancer trial led by University of Minnesota Medical School's Dr. Clark Chen shows promise

Fri, 27 Oct 17 00:07:30 -0700

New data from a Phase I clinical trial led by Clark Chen, M.D., Ph.D., Lyle French Chair in Neurosurgery and Head of the University of Minnesota Medical School Department of Neurosurgery shows more than a quarter of patients with recurrent high-grade glioma, a form of brain cancer, were alive more than three years after treatment.